Composition for recovering measles virus, and kit, purpose and method thereof

A measles virus and composition technology, applied in antiviral agents, biochemical equipment and methods, virus/bacteriophage, etc., can solve problems such as difficulty in rescue, complicated rescue system and method, and reduce homology and excellent virus The effect of the rescue effect

Active Publication Date: 2013-06-19
NAT VACCINE & SERUM INST
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Inoue K et al successfully rescued rabies virus by using RNA virus reverse genetics system (Inoue K, Shoji Y, Kurane I, Iijima T, Sakai T, Morimoto K.An improved method for recovering rabies virus from cloned cDNA.J Virol Methods.2003 , 1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for recovering measles virus, and kit, purpose and method thereof
  • Composition for recovering measles virus, and kit, purpose and method thereof
  • Composition for recovering measles virus, and kit, purpose and method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Embodiment 1: Construction of transcription vector and expression vector

[0068] 1. Nucleic acid sequence mutation modification

[0069] The original sequence of the vector plasmid pVAX1 (purchased from Invitrogen, with a CMV promoter) was modified, and the 34th base T mutation was designed to be G, and the 50th base A mutation was designed to be T, thereby eliminating the MluI enzyme Cutting site and SpeI restriction site, and its 725th-730th base sequence AGCTCG mutation is designed as ACGCGT, so that the multiple cloning site of the vector plasmid has a MluI restriction site. The designed vector plasmid sequence (produced by Shanghai Jierui Bioengineering Co., Ltd.) was synthesized and transformed, and it was named pVAXm. The carrier plasmid sequence was sequenced and identified (by Takara Company), and the obtained sequence is shown in SEQ ID No.: 1 in the sequence listing.

[0070] The hammerhead ribozyme sequence and hepatitis D virus ribozyme sequence were res...

Embodiment 2

[0084] Example 2: Screening for suitable host cells

[0085] 1. Cell Transfection

[0086] Vero cells (purchased from Shanghai Cell Resource Center) and 293T cells (purchased from Shanghai Cell Resource Center) were subcultured at 1:1, respectively, and 5×10 5 Cells were plated in the wells of a 6-well plate; BHK-21 cells (purchased from Shanghai Cell Resource Center) were subcultured at 1:2, and 5×10 5cells / well were plated in 6-well plates. When the cells in the six-well plate were fused to a density of 80-90%, the three cell lines were transfected with three expression vectors pVAXm-N, pVAXm-P and pVAXm-L, as follows:

[0087] Solution 1: Dilute 10 μl / well transfection agent (lipofectamine 2000, available from Invitrogen) with 240 μl / well serum-free medium, and mix gently at room temperature for 5 minutes; Solution 2: Dilute with 10 μl / well serum-free medium 4 μg / well expression vector; mix solution 1 with solution 2 and let stand at room temperature for 20 minutes. At ...

Embodiment 3

[0091] Example 3: Rescue of measles virus

[0092] 1. Co-transfection

[0093] Put the sterilized coverslips into the wells of the six-well culture plate, then add 2mLoptimem (available from GIBCO) medium, and add 8×10 5 293T cells were plated in the wells of a 6-well plate at 37°C, 5% CO 2 cultured overnight. Afterwards, co-transfect the cells with the transcription vector constructed above and the three expression vectors, as follows:

[0094] After mixing the transfection agent (lipofectamine 2000, which can be purchased from Invitrogen Company), 10 μl / well was pipetted, diluted with 100 μl optimem (GIBCO) medium, and allowed to stand at room temperature for 5 minutes. Afterwards, the four vectors were diluted with 100 μl of optimem (GIBCO) medium, and the proportions of the four vectors are shown in Table 1 (Groups 1-11). After mixing them with the diluted transfection agent, they were left at room temperature for 20 minutes. Add 500 μl / well of the above mixture dropwi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a composition for recovering measles virus, and a kit, a purpose and a method thereof. The composition for recovering measles virus of the present invention comprises: 1) a recombinant transcription vector, which contains the measles virus whole genome cDNA, wherein the 5' and 3' ends of the measles virus whole genome respectively includes a ribozyme sequence with self-cleavage function; 2) a first recombinant expression vector, which includes an encoding gene of nucleocapsid protein of measles virus; 3) a second recombinant expression vector, which includes the encoding gene of measles virus phosphoprotein; and 4) a third recombinant expression vector, which includes an encoding gene of RNA polymerase of measles virus. The composition of the present invention can simply and easily recover measles virus, and the recovered measles virus can be used for preparing a measles vaccine. The composition is suitable for industrial applications.

Description

technical field [0001] The invention belongs to the field of bioengineering, in particular, the invention relates to a composition for rescuing measles virus, a kit containing the composition, an application of the composition and a method for rescuing measles virus. Background technique [0002] Measles virus (MV), a member of the genus morbillivirus in the Paramyxoviridae family, is an enveloped virus containing unsegmented linear single-stranded RNA that passes through respiratory droplets, or Contact infection. The incidence of measles in susceptible populations is almost 100%, so the measles virus is one of the viruses that cause highly contagious diseases worldwide. [0003] The domestically used measles vaccine strain is Shanghai 191 (S191) strain (NCBI number: EU435017.1), which was isolated from the blood of a 2-year-old male measles patient in Shanghai in 1960. The measles vaccine produced by the Shanghai 191 strain has good stability, good clinical safety and im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/00A61K39/165A61P31/14
Inventor 王健陈祥鹏孙丽媛李莉莉张振龙沈心亮
Owner NAT VACCINE & SERUM INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products